FDA lifts curbs on Indian maker of malaria drug touted by Donald Trump as a Covid counter
Hydroxychloroquine is being snapped up by medical systems at more than twice the typical pace as U.S. hospitals seek to build large inventories in anticipation of the medication ’s potential use in patients with Covid-19.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: American Health | Biotechnology | COVID-19 | Hospitals | Hydroxychloroquine | India Health | Malaria | Pharmaceuticals | Trump | USA Health